Multivariate relationships between international normalized ratio and vitamin K-dependent coagulation-derived parameters in normal healthy donors and oral anticoagulant therapy patients

被引:16
作者
Cezary Watala
Jacek Golanski
Przemyslaw Kardas
机构
[1] Dept. of Haemost./Haemostasis Dis., Medical University of Lodz, Lodz
[2] Department of Family Medicine, Medical University of Lodz, Lodz
关键词
Clotting factors; International Normalized Ratio (INR) of prothrombin time; Multivariate analysis; Protein C; Prothrombin fragment F1+2;
D O I
10.1186/1477-9560-1-7
中图分类号
学科分类号
摘要
Background and objectives: International Normalized Ratio (INR) is a world-wide routinely used factor in the monitoring of oral anticoagulation treatment (OAT). However, it was reported that other factors, e. g. factor II, may even better reflect therapeutic efficacy of OAT and, therefore, may be potentialy useful for OAT monitoring. The primary purpose of this study was to characterize the associations of INR with other vitamin K-dependent plasma proteins in a heterogenous group of individuals, including healthy donors, patients on OAT and patients not receiving OAT. The study aimed also at establishing the influence of co-morbid conditions (incl. accompanying diseases) and co-medications (incl. different intensity of OAT) on INR. Design and Methods: Two hundred and three subjects were involved in the study. Of these, 35 were normal healthy donors (group I), 73 were patients on medication different than OAT (group II) and 95 were patients on stable oral anticoagulant (acenocoumarol) therapy lasting for at least half a year prior to the study. The values of INR and activated partial thromboplastin time (APTT) ratio, as well as activities of FII, FVII, FX, protein C, and concentration of prothrombin F1+2 fragments and fibrinogen were obtained for all subjects. In statistical evaluation, the uni- and multivariate analyses were employed and the regression equations describing the obtained associations were estimated. Results: Of the studied parameters, three (factors II, VII and X) appeared as very strong modulators of INR, protein C and prothrombin fragments F1+2 had moderate influence, whereas both APTT ratio and fibrinogen had no significant impact on INR variability. Due to collinearity and low tolerance of independent variables included in the multiple regression models, we routinely employed a ridge multiple regression model which compromises the minimal number of independent variables with the maximal overall determination coefficient. The best-fitted two-component model included FII and FVII activities and explained 90% of INR variability (compared to 93% in the 5-component model including all vitamin K-dependent proteins). Neither the presence of accompanying diseases nor the use of OAT nor any other medication (acetylsalicylic acid, statins, steroids, thyroxin) biased significantly these associations. Conclusion: Among various vitamin K-dependent plasma proteins, the coagulation factors II, VII and X showed the most significant associations with INR. Of these variables, the two-component model, including factors II and VII, deserves special attention, as it largely explains the overall variability observed in INR estimates. The statistical power of this model is validated on virtue of the estimation that the revealed associations are rather universal and remain essentially unbiased by other compounding variables, including clinical status and medical treatment. Further, much broader population studies are needed to verify clinical usefulness of methods alternate or compounding to INR monitoring of OAT. © 2003 Watala et al; licensee BioMed Central Ltd.
引用
收藏
页数:10
相关论文
共 24 条
[1]  
Hirsh J., Dalen J., Anderson D.R., Poller L., Bussey H., Ansell J., Deykin D., Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range, Chest, 119, (2001)
[2]  
Hirsh J., Dalen J., Guyatt G., The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis, Chest, 119, (2001)
[3]  
Palmer R.N., Kessler C.M., Gralnick H.R., Warfarin anticoagulation: Difficulties in interpretation of the prothrombin time, Thromb. Res., 25, pp. 125-130, (1982)
[4]  
D'Angelo A., Della V.P., Crippa L., Fattorini A., Pattarini E., Vigano D.S., Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo pro-thrombin activation during the early and steady phases of oral anticoagulant treatment, Haematologica, 87, pp. 1074-1080, (2002)
[5]  
Tripodi A., Cattaneo M., Molteni A., Cesana B.M., Mannucci P.M., Changes of prothrombin fragment 1+2 (F 1+2) as a function of increasing intensity of oral anticoagulation - Considerations on the suitability of F 1+2 to monitor oral anticoagulant treatment, Thromb. Haemost., 79, pp. 571-573, (1998)
[6]  
Koefoed B.G., Feddersen C., Gullov A.L., Petersen P., Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation, Thromb. Haemost., 77, pp. 845-848, (1997)
[7]  
Bruhn H.D., Conard J., Mannucci M., Monteagudo J., Pelzer H., Reverter J.C., Samama M., Tripodi A., Wagner C., Multicentric evaluation of a new assay for prothrombin fragment F1+2 determination, Thromb. Haemost., 68, pp. 413-417, (1992)
[8]  
Lind S.E., Callas P.W., Golden E.A., Joyner Jr. K.A., Ortel T.L., Plasma levels of factors II, VII and X and their relationship to the international normalized ratio during chronic warfarin therapy, Blood Coagul. Fibrinolysis, 8, pp. 48-53, (1997)
[9]  
Weinstock D.M., Chang P., Aronson D.L., Kessler C.M., Comparison of plasma prothrombin and factor VII and urine prothrombin F1 concentrations in patients on long-term warfarin therapy and those in the initial phase, Am. J. Hematol., 57, pp. 193-199, (1998)
[10]  
De Muth J.E., Basic statistics and pharmaceutical statistical applications, (1999)